Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-03-13 00:00:00 ET · period of report 2024-03-11 · accession 0001415889-24-007804 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-13 | 2024-03-11 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $2.03 | +65.0K | 477.8K | +16% | +$131.9K |
| D | 2024-03-13 | 2024-03-11 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $0.00 | -65.0K | 227.3K | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-11 | M | A | 65,000 | $2.03 | 477,847 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2024-03-11 | M | D | 65,000 | $0.00 | 227,327 | D | $2.03 · — to 2028-07-23 | 65,000 Common Stock | (F3) Stock Option is fully vested and exercisable. |